EPINEPHRINE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency, acting under the Department of Defense, issued award SPE2D227F0021 on October 13, 2026, to DMS Pharmaceutical Group Inc. This specific delivery order was placed under the broader administrative contract SPE2DX25D9822, which is part of the Pharmaceutical Prime Vendor Global Generation S program. The overarching base contract, SPE2DX25D9000, carries a total award value of 20 million dollars and became effective on March 7, 2025. This particular order is for the procurement of Epinephrine Injection, identified by NSN 6505016682549 and PR 7018722512. The contract specifies a quantity of 1.000 PG at a total price of 34.24 dollars. The designated delivery destination for these medical supplies is the USS IOWA via Submarine Base New London.
General Info
Contract Value
$34.24Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
